Target's General Information
Target ID T76285
Target Name Phosphodiesterase I beta (ENPP3)
Synonyms Phosphodiesterase I/nucleotide pyrophosphatase 3; PDNP3; PD-Ibeta; NPP3; Ectonucleotide pyrophosphatase/phosphodiesterase family member 3; E-NPP 3; CD203c
Target Type Clinical trial
Gene Name ENPP3
Biochemical Class Phosphoric diester hydrolase
UniProt ID ENPP3_HUMAN
Target's Expression Profile in Disease Related Tissue between Patients and Normal People
Disease Renal cancer
Example drug AGS-16M8F Phase 1 [1], [2], [3]
Tissue Kidney
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual Fold-change: 3.44
Z-score: 9.16
P-value: 4.95E-20
Level of differential expression between the patients in the disease section of the tissue section of the tissue adjacent to the disease section Fold-change: 3.34
Z-score: 2.84
P-value: 6.62E-21
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles of the patients in the normal section of the tissue adjacent to the disease section
Target gene expression profiles in the tissue of healthy individual
Target's Expression Profile across Various Tissues of Healthy Individual
References
REF 1 ClinicalTrials.gov (NCT01114230) A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer. U.S. National Institutes of Health.
REF 2 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
REF 3 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.